Adium is a Latin American pharmaceutical company that produces, promotes and commercializes both primary care and specialty / oncology care therapies. Founded in 1971, Adium has subsidiaries in eighteen countries including Mexico, Brazil, Argentina and Central America with over 2000 pharmaceutical sales representatives. Adium represents international pharma and biotech companies in Latin America, such as BMS, Amgen, Astellas, Jazz Pharmaceuticals, Tolmar, Debiopharm and Meiji Seika,Japan.